rs140468930

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005026.5(PIK3CD):​c.1953C>T​(p.Leu651Leu) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00841 in 1,612,992 control chromosomes in the GnomAD database, including 806 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0098 ( 65 hom., cov: 32)
Exomes 𝑓: 0.0083 ( 741 hom. )

Consequence

PIK3CD
NM_005026.5 splice_region, synonymous

Scores

2
Splicing: ADA: 0.006946
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.974

Publications

2 publications found
Variant links:
Genes affected
PIK3CD (HGNC:8977): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta) Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I PI3K found primarily in leukocytes. Like other class I PI3Ks (p110-alpha p110-beta, and p110-gamma), the encoded protein binds p85 adapter proteins and GTP-bound RAS. However, unlike the other class I PI3Ks, this protein phosphorylates itself, not p85 protein.[provided by RefSeq, Jul 2010]
PIK3CD Gene-Disease associations (from GenCC):
  • immunodeficiency 14
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • immunodeficiency 14b, autosomal recessive
    Inheritance: AR, Unknown Classification: DEFINITIVE, MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • activated PI3K-delta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 1-9721585-C-T is Benign according to our data. Variant chr1-9721585-C-T is described in ClinVar as Benign. ClinVar VariationId is 474025.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.974 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0662 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIK3CDNM_005026.5 linkc.1953C>T p.Leu651Leu splice_region_variant, synonymous_variant Exon 15 of 24 ENST00000377346.9 NP_005017.3 O00329-1A0A2K8FKV1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIK3CDENST00000377346.9 linkc.1953C>T p.Leu651Leu splice_region_variant, synonymous_variant Exon 15 of 24 1 NM_005026.5 ENSP00000366563.4 O00329-1

Frequencies

GnomAD3 genomes
AF:
0.00981
AC:
1493
AN:
152216
Hom.:
63
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00150
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0694
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00750
Gnomad SAS
AF:
0.0446
Gnomad FIN
AF:
0.00546
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000617
Gnomad OTH
AF:
0.00765
GnomAD2 exomes
AF:
0.0295
AC:
7343
AN:
249322
AF XY:
0.0254
show subpopulations
Gnomad AFR exome
AF:
0.000995
Gnomad AMR exome
AF:
0.157
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00902
Gnomad FIN exome
AF:
0.00604
Gnomad NFE exome
AF:
0.000676
Gnomad OTH exome
AF:
0.0225
GnomAD4 exome
AF:
0.00826
AC:
12065
AN:
1460658
Hom.:
741
Cov.:
35
AF XY:
0.00847
AC XY:
6157
AN XY:
726604
show subpopulations
African (AFR)
AF:
0.00111
AC:
37
AN:
33466
American (AMR)
AF:
0.150
AC:
6716
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0139
AC:
552
AN:
39696
South Asian (SAS)
AF:
0.0425
AC:
3667
AN:
86212
European-Finnish (FIN)
AF:
0.00639
AC:
338
AN:
52868
Middle Eastern (MID)
AF:
0.000945
AC:
5
AN:
5292
European-Non Finnish (NFE)
AF:
0.000246
AC:
273
AN:
1111988
Other (OTH)
AF:
0.00791
AC:
477
AN:
60304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
885
1770
2655
3540
4425
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
162
324
486
648
810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00983
AC:
1498
AN:
152334
Hom.:
65
Cov.:
32
AF XY:
0.0115
AC XY:
854
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00149
AC:
62
AN:
41576
American (AMR)
AF:
0.0697
AC:
1066
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00752
AC:
39
AN:
5188
South Asian (SAS)
AF:
0.0445
AC:
215
AN:
4834
European-Finnish (FIN)
AF:
0.00546
AC:
58
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000617
AC:
42
AN:
68024
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
80
160
239
319
399
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00280
Hom.:
7
Bravo
AF:
0.0157
Asia WGS
AF:
0.0330
AC:
114
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000356

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 10, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Immunodeficiency 14 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
13
DANN
Benign
0.79
PhyloP100
0.97
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=40/60
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0069
dbscSNV1_RF
Benign
0.42
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140468930; hg19: chr1-9781643; API